4.5 Review

Sexuality, pelvic floor/vaginal health and contraception at menopause

Journal

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.bpobgyn.2021.11.006

Keywords

Menopause Female sexual dysfunction (FSD); Hypoactive sexual desire disorder (HSDD); Genitourinary syndrome of menopause (GSM); Vulvovaginal atrophy (VVA); Contraception

Ask authors/readers for more resources

This article summarizes key points for approaching sexual symptoms in midlife women, providing principles for diagnosing and managing hypoactive sexual desire disorder and genitourinary syndrome of menopause/vulvovaginal atrophy, as well as managing contraceptive needs.
A multitude of biopsychosocial factors influences sexual health at midlife, a common concern in daily practice along with vaginal and pelvic health. Health-care providers (HCPs) need to be proactive in dealing with possible symptoms because in most cases early management prevents distress and improves quality of life. Female sexual dysfunctions (FSDs) may have a complex etiology but sexual history is not difficult implementing basic knowledge of risk factors and some skills helping women to cope with hormonal and age-related changes. This work summarizes key points to approach sexual symptoms in midlife women, providing principles to diagnose and manage hypoactive sexual desire disorder (HSDD) and genitourinary syndrome of menopause (GSM)/vulvovaginal atrophy (VVA), as well as manage contraceptive needs. (c) 2021 Published by Elsevier Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available